Announce your event here
GP2A-JFB 2018
2018-06-13 to 2018-06-15
Asnelles sur Mer (Normandie), France

The congress entitled "32èmes Journées Franco-Belges de Chimie Thérapeutique et 26èmes Conférences Européennes des Pharmacochimistes de l'Arc Atlantique", will take place between 13th and 15th June 2018 in "Les Tourelles Centre" on the beach of Asnelles-sur-Mer near Arromanches (Normandie, France).
The registration are open on : https://gp2a-jfb2018.sciencesconf.org
It is still possible to propose PhD short communications (5 min), Young Researcher communications (15 min), or Poster communications.

Numerous prizes will be awarded.

Registrations are open until April 30th 2018
All details concerning the scientific program and accommodation are available on offical webpage.

http://gp2a.org/external link

XXV EFMC International Symposium on Medicinal Chemistry
2018-09-02 to 2018-09-06
Ljubljana, Slovenia

The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) will be organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (SFD), on behalf of the European Federation for Medicinal Chemistry (EFMC).

The EFMC is the main organisation for European Medicinal Chemistry community, with 27 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in its field and attracts traditionally around 1200 participants, from industry and academia. Recent EFMC-ISMC meetings have taken place in Belgium (Brussels, 2010), Germany (Berlin, 2012), Portugal (Lisbon, 2014) and most recently in the United Kingdom (Manchester, 2016).

The symposium will take place in Ljubljana from September 2-6, 2018.

The 2018 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.

https://www.ldorganisation.com/v2/produits.php?langue=english&cle_menus=1238916301&cle_data=1360153464external link

XXXVIII Convegno Nazionale della Divisione di Chimica Organica–CDCO2018
2018-09-09 to 2018-09-13
Milan, Italy

Il XXXVIII Convegno Nazionale della Divisione di Chimica Organica della Società Chimica Italiana si svolgerà a Milano dal 9 al 13 settembre 2018. L’organizzazione di questa edizione del Convegno è curata dalla Divisone di Chimica Organica della Società Chimica Italiana con il supporto dell’Università degli Studi di Milano e dell’Università degli Studi di Milano-Bicocca, e con la collaborazione di Federchimica e Assolombarda.
Il Convegno, come da tradizione, è aperto all’accademia, agli enti di ricerca, all’industria, alla scuola ed alle istituzioni attive in tutti i settori della chimica organica ed in quelli interdisciplinari ad essa collegati, con lo scopo di stimolare discussioni e promuovere proficui scambi scientifici.

http://www.cdco2018.it/index.htmlexternal link

Fifth Annual Re-Entering Antibacterial Discovery and Development Summit
2018-09-25 to 2018-09-28
Boston, MA, USA
We are witnessing rapidly unfolding efforts to reinvigorate the antibacterial pipeline, improve antimicrobial stewardship and bring the multidrug microbial resistance under control. Industry, academia and government entities are working together on sustainable solutions for the antibiotic resistance crisis. Multidrug-resistant Gram-negative bacteria currently pose the biggest threat and attract the most attention from researchers and policy makers. Novel platforms, screening strategies and new drugs as well as new pathways for clinical development and market access are needed to overcome the current state of emergency associated with multidrug-resistant bacteria. Cambridge Healthtech Institute's 5th Annual Re-Entering Antibacterial Discovery and Development Summit is designed as a knowledge and experience exchange for the major stakeholders working in this important area. The Summit features two conferences, Antibacterial Discovery and Development (September 26-27) and Targeting Gram-Negative Pathogens (September 27-28), and several short courses.

http://www.antibacterialdrugdevelopmentsummit.com/external link